Loading

logo

Journal of Clinical and Experimental Gastroenterology

ISSN: 2833-1133

Mini Review Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.46439/gastro.1.009

A mini-review of the associations between hypertension and risk of gallstone disease

Xin Wang1,#,*, Fulan Hu2,#, Yanmei Lou3,#, Jing Xia4,#, Wenqian Yu1, Min Zhang5, Fengju Song6, Qi Chen7, Feng Rui8, Chi Zhang9, Ping Cui10, Lingxi Kong11, Pei Zhu1, Guangcan Li12, Min Mao13, Xuefeng Shan11
  • 1Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China
  • 2Department of Epidemiology and Health Statistics, School of Public Health, Shenzhen University Health Science Center, Shenzhen, Guangdong 518061, China
  • 3Department of Health Management, Beijing Xiaotangshan Hospital, Beijing 102211, China
  • 4Graduate faculty, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China
  • 5School of Public Health and Management, Chongqing Medical University, Chongqing 400016, China
  • 6Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
  • 7Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
  • 8Department of Pharmacy, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
  • 9Department of Prevention, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
  • 10Department of Public Health, Jining Medical University, Jining 272067, China
  • 11Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
  • 12Department of Pharmacy, The People’s Hospital of Kaizhou District, Chongqing 405400, China
  • 13Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu 610041, China
  • #These authors contributed equally
+ Affiliations - Affiliations

Corresponding Author

 Xin Wang, wangxinmarine@126.com

Received Date: November 10, 2022

Accepted Date: November 23, 2022

Citation:

Wang X, Hu F, Lou Y, Xia J, Yu W, Zhang M, et al. A mini-review of the associations between hypertension and risk of gallstone disease. J Clin Exp Gastroenterol. 2022;1(1):45-52.


Copyright: © 2022 Wang X, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

A series of studies suggested that hypertension is significantly associated with the risk of gallstone disease (GSD). However, due to differences in study design, population stratification, sample size, and diagnostic criteria for GSD, the results of each study are inconsistent, limiting the strength and application of these pieces of evidence. We previously conducted a cross-sectional study incorporating over 300,000 population, and the results showed hypertension was significantly associated with the risk of GSD. However, it was a single-center study, and the external generalization of research results is limited to a certain extent. Thus, we conducted another multi-center study and a systematic review and meta-analysis to verify further the relationship between hypertension and the risk of GSD. 

Keywords

Gallstone diseases, Hypertension, Multi-center study, Systematic review and meta-analysis

Recommended Articles

Hypertension and comorbidities: A silent threat to global health

Worldwide, hypertension is a substantial cause of cardiovascular disease and premature death. In the past few decades, global mean blood pressure has been somewhat stable and decreased due to the advancement and utilization of antihypertensive medications [1]. According to the Sept. 2023 WHO report, Hypertension affects 1 in 3 adults worldwide, among which 4 out of every 5 people are not effectively treated. 

A mini-review of the associations between hypertension and risk of gallstone disease

A series of studies suggested that hypertension is significantly associated with the risk of gallstone disease (GSD). However, due to differences in study design, population stratification, sample size, and diagnostic criteria for GSD, the results of each study are inconsistent, limiting the strength and application of these pieces of evidence. 

Therapeutic antibody approach for pulmonary arterial hypertension

GMA301 is a novel antagonistic antibody in clinical development. GMA301 targets human endothelin receptor A (ETA), a proven therapeutic target for pulmonary arterial hypertension (PAH).

Fumarate hydratase as a potential target to ameliorate salt sensitive hypertension

Salt sensitive hypertension is a major risk factor for stroke, heart failure, and end-stage renal disease [1]. The development of salt sensitive hypertension is involved in genetic and environmental factors. Excessive dietary salt intake is known as a main risk factor and one of the most important environmental determinants, exacerbates the salt sensitive hypertension by a renal redox metabolism [2,3].

Omecamtiv mecarbil for heart failure: Unpacking the latest systematic review and meta-analysis

In February 2023, a systematic review and meta-analysis of six randomized controlled trials (RCTs) with a total of 9,596 patients assessed the effectiveness and safety of omecamtiv mecarbil (OM) versus placebo in patients with heart failure with reduced left ventricular ejection fraction (HFrEF) [1]. 

Full Text
Cite
Download PDF
Author Information X